Advanced Enzyme Technologies Limited (ADVENZYMES.NS) NSE

Currency In INR

AD

Valuation

Market Cap28.56B
Enterprise Value27.72B
P/E Ratio18.55
PEG Ratio1.15
Price/Sales Ratio4.07
Price/Book Ratio1.9
Enterprise/Revenue3.9
Enterprise/EBITDA11.58

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.22
Operating Margin0.25
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.1

Income Statement

Revenue7.46B
Revenue/Share69.88
Gross Profit3.5B
EBITDA2.75B
Net Income1.69B
Diluted EPS15.06

Balance Sheet

Total Cash6.73B
Total Cash/Share60.3
Total Debt536.99M
Total Debt/Equity0.03
Current Ratio8.91
Book Value Per Share154.17

Price History

52-Week Change-8.3
52-Week High419
52-Week Low246.8
Moving Average 50 Days278.44
Moving Average 200 Days309.88

Statistics

Average Volume232,507
Shares Outstanding111.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.35
Trailing Annual Dividend Yield0.48
Payout Ratio0.34
Last Split Factor5:1
Last Split DateMay 25, 2017
AD